These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
86 related articles for article (PubMed ID: 21720224)
1. A randomized open-label comparison of the impact of aripiprazole versus risperidone on sexual functioning (RAS study). de Boer MK; Wiersma D; Bous J; Sytema S; van der Moolen AE; Wilffert B; Hamamura T; Knegtering H J Clin Psychopharmacol; 2011 Aug; 31(4):523-5. PubMed ID: 21720224 [No Abstract] [Full Text] [Related]
2. Changes in sexual function and gonadal axis hormones after switching to aripiprazole in male schizophrenia patients: a prospective pilot study. Jeong HG; Lee MS; Lee HY; Ko YH; Han C; Joe SH Int Clin Psychopharmacol; 2012 Jul; 27(4):177-83. PubMed ID: 22407277 [TBL] [Abstract][Full Text] [Related]
3. Improvement of serum prolactin and sexual function after switching to aripiprazole from risperidone in schizophrenia: a case series. Chen CY; Lin TY; Wang CC; Shuai HA Psychiatry Clin Neurosci; 2011 Feb; 65(1):95-7. PubMed ID: 21265942 [TBL] [Abstract][Full Text] [Related]
4. Switching to aripiprazole in outpatients with schizophrenia experiencing insufficient efficacy and/or safety/tolerability issues with risperidone: a randomized, multicentre, open-label study. Ryckmans V; Kahn JP; Modell S; Werner C; McQuade RD; Kerselaers W; Lissens J; Sanchez R Pharmacopsychiatry; 2009 May; 42(3):114-21. PubMed ID: 19452380 [TBL] [Abstract][Full Text] [Related]
5. Aripiprazole, an antipsychotic with a novel mechanism of action, and risperidone vs placebo in patients with schizophrenia and schizoaffective disorder. Potkin SG; Saha AR; Kujawa MJ; Carson WH; Ali M; Stock E; Stringfellow J; Ingenito G; Marder SR Arch Gen Psychiatry; 2003 Jul; 60(7):681-90. PubMed ID: 12860772 [TBL] [Abstract][Full Text] [Related]
6. A randomized open-label study of the impact of quetiapine versus risperidone on sexual functioning. Knegtering R; Castelein S; Bous H; Van Der Linde J; Bruggeman R; Kluiter H; van den Bosch RJ J Clin Psychopharmacol; 2004 Feb; 24(1):56-61. PubMed ID: 14709948 [TBL] [Abstract][Full Text] [Related]
7. Time course of the changes in antipsychotic-induced hyperprolactinemia following the switch to aripiprazole. Lu ML; Shen WW; Chen CH Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1978-81. PubMed ID: 18848860 [TBL] [Abstract][Full Text] [Related]
8. Effectiveness of switching from aripiprazole to ziprasidone in patients with schizophrenia. Kim SW; Shin IS; Kim JM; Bae KY; Yang SJ; Yoon JS Clin Neuropharmacol; 2010 May; 33(3):121-5. PubMed ID: 20502130 [TBL] [Abstract][Full Text] [Related]
9. Comment on "dose-dependent effects of adjunctive treatment with aripiprazole on hyperprolactinemia induced by risperidone in female patients with schizophrenia". Ishitobi M; Kosaka H; Shukunami K; Murata T; Wada Y J Clin Psychopharmacol; 2011 Jun; 31(3):400-1; author reply 401. PubMed ID: 21532377 [No Abstract] [Full Text] [Related]
10. Dose-dependent increase in the QTc interval in aripiprazole treatment after risperidone. Suzuki Y; Ono S; Fukui N; Sugai T; Watanabe J; Tsuneyama N; Someya T Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):643-4. PubMed ID: 21044656 [No Abstract] [Full Text] [Related]
11. Successful monotherapy treatment with aripiprazole in a patient with schizophrenia and prolactinoma. Freeman B; Levy W; Gorman JM J Psychiatr Pract; 2007 Mar; 13(2):120-4. PubMed ID: 17414690 [No Abstract] [Full Text] [Related]
12. A randomized open-label comparison of the impact of olanzapine versus risperidone on sexual functioning. Knegtering H; Boks M; Blijd C; Castelein S; van den Bosch RJ; Wiersma D J Sex Marital Ther; 2006; 32(4):315-26. PubMed ID: 16709552 [TBL] [Abstract][Full Text] [Related]
13. A comparative study of sexual dysfunction in schizophrenia patients taking aripiprazole versus risperidone. Shah SK Kathmandu Univ Med J (KUMJ); 2013; 11(42):121-5. PubMed ID: 24096218 [TBL] [Abstract][Full Text] [Related]
14. Persistent hiccups associated with switching from risperidone to aripiprazole in a schizophrenic patient with cerebral palsy. Yeh YW Clin Neuropharmacol; 2011; 34(4):135-6. PubMed ID: 21768798 [TBL] [Abstract][Full Text] [Related]
15. Dose-dependent effects of adjunctive treatment with aripiprazole on hyperprolactinemia induced by risperidone in female patients with schizophrenia. Yasui-Furukori N; Furukori H; Sugawara N; Fujii A; Kaneko S J Clin Psychopharmacol; 2010 Oct; 30(5):596-9. PubMed ID: 20814333 [TBL] [Abstract][Full Text] [Related]
16. Aripiprazole for treatment-resistant schizophrenia: results of a multicenter, randomized, double-blind, comparison study versus perphenazine. Kane JM; Meltzer HY; Carson WH; McQuade RD; Marcus RN; Sanchez R; J Clin Psychiatry; 2007 Feb; 68(2):213-23. PubMed ID: 17335319 [TBL] [Abstract][Full Text] [Related]
17. Use of aripiprazole in tardive dyskinesia: an open label study of six cases. Rajarethinam R; Dziuba J; Manji S; Pizzuti A; Lachover L; Keshavan M World J Biol Psychiatry; 2009; 10(4 Pt 2):416-9. PubMed ID: 19492247 [TBL] [Abstract][Full Text] [Related]
18. Psychosis associated with switching from risperidone to aripiprazole in an adolescent on methylphenidate treatment. Ekinci O; Sabuncuoglu O Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):648-9. PubMed ID: 21134409 [No Abstract] [Full Text] [Related]
19. The neurocognitive effects of aripiprazole compared with risperidone in the treatment of schizophrenia. Sato G; Yoshimura S; Yamashita H; Okamoto Y; Yamawaki S Hiroshima J Med Sci; 2012 Dec; 61(4):75-83. PubMed ID: 23342824 [TBL] [Abstract][Full Text] [Related]
20. Successful switch to aripiprazole after induction of hyperprolactinemia by ziprasidone: a case report. Anghelescu I; Wolf J J Clin Psychiatry; 2004 Sep; 65(9):1286-7. PubMed ID: 15367061 [No Abstract] [Full Text] [Related] [Next] [New Search]